A Randomized Study to Compare the Efficacy Between Intranasal and Intravenous Dexmedetomidine for the Removal of Foreign Bodies in the Esophagus at the Cricopharynx Level in Pediatric Patients
2024

Comparing Intranasal and Intravenous Dexmedetomidine for Pediatric Foreign Body Removal

Sample size: 80 publication Evidence: high

Author Information

Author(s): Muacevic Alexander, Adler John R, Kumar Manoj, Mishra Prashant, Singh Amit K, Gupta Rahul

Primary Institution: Uttar Pradesh University of Medical Sciences, Etawah, IND

Hypothesis

Is intranasal dexmedetomidine more effective than intravenous dexmedetomidine for sedation during foreign body removal in pediatric patients?

Conclusion

Intranasal administration of dexmedetomidine is safer and more effective for sedation in pediatric patients undergoing foreign body removal from the esophagus.

Supporting Evidence

  • The mean time to shift patients to the operation theater was significantly longer for the intranasal group.
  • Intranasal dexmedetomidine provided longer postoperative pain relief compared to intravenous dexmedetomidine.
  • Group B (IV) had significantly lower pain scores at 10 minutes compared to Group A (IN).
  • Group A (IN) showed stable hemodynamic parameters compared to Group B (IV).
  • The Ramsay Sedation Score was higher at 10 and 20 minutes in the IV group compared to the IN group.

Takeaway

This study found that giving a nose spray of a medicine called dexmedetomidine is better and safer than giving it through an IV for kids who need help with removing things they swallowed.

Methodology

This was a double-blinded, randomized controlled study involving 80 pediatric patients who were divided into two groups to receive either intranasal or intravenous dexmedetomidine before endoscopic foreign body removal.

Limitations

The study was limited to a single institution and only included pediatric patients undergoing specific procedures, which may affect the generalizability of the results.

Participant Demographics

Pediatric patients aged one month to 12 years, ASA PS I and II.

Statistical Information

P-Value

0.001

Confidence Interval

95% CI of the difference: 21.4 to 24.8

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.7759/cureus.73909

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication